Idom Mite

Dosulepin Hydrochloride, the active ingredient in Idom Mite, is a tricyclic antidepressant presented as an oral dosage form for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to alleviate depressive symptoms by modulating neurotransmitter activity.

GNH USA supplies Idom Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Our global logistics network ensures timely delivery to authorized healthcare providers.

Dosulepin Hydrochloride is a tricyclic antidepressant used primarily in the management of mood disorders.

- Major depressive disorder: reduces depressive symptoms and improves overall mood. - Depressive disorder with somatic symptoms: alleviates physical manifestations such as fatigue and pain. - Anxiety associated with depression: helps control excessive worry and tension in patients with depressive illness.

Dosulepin Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dry mouth: reduced salivation leading to discomfort. - Drowsiness: increased sedation, especially after dose initiation. - Constipation: slowed gastrointestinal motility. - Orthostatic hypotension: dizziness upon standing.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening. - Seizures: risk of convulsive episodes, particularly at high doses. - Severe hypotension: marked drop in blood pressure causing fainting. - Hepatic dysfunction: abnormal liver enzymes indicating possible liver injury.

When prescribing Dosulepin Hydrochloride, clinicians should consider several safety measures.

- Cardiovascular assessment: evaluate history of heart disease before initiating therapy. - Suicidality monitoring: observe for worsening depression or emergence of suicidal thoughts. - Drug interaction review: check for concurrent serotonergic or MAO‑inhibiting agents. - Pregnancy and lactation: use only if potential benefits outweigh potential risks. - Elderly patients: start at low dose and monitor for anticholinergic effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Dosulepin Hydrochloride interacts with several medication classes; careful management is required.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs): potential serotonin syndrome. - Linezolid or other reversible MAO inhibitors: heightened serotonergic activity.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: additive anticholinergic burden may increase dry mouth, constipation, and confusion. - Central nervous system depressants (e.g., benzodiazepines, alcohol): enhanced sedation and respiratory depression. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise dosulepin plasma levels, requiring dose adjustment.